Human Genome Epidemiology Literature Finder
|
Records 1 - 7 (of 7 Records) |
| Query Trace: Neoplasms and FPR1[original query] |
|---|
| Polymorphisms of the formylpeptide receptor gene (FPR1) and susceptibility to stomach cancer in 1531 consecutive autopsy cases. Biochemical and biophysical research communications 2011 Feb 405 (3): 356-61. Otani Tatsuro, Ikeda Shinobu, Lwin Htay, Arai Tomio, Muramatsu Masaaki, Sawabe Moto |
| Pattern Recognition Receptor Polymorphisms as Predictors of Oxaliplatin Benefit in Colorectal Cancer. Journal of the National Cancer Institute 2019 Jan . Gray Victoria, Briggs Sarah, Palles Claire, Jaeger Emma, Iveson Timothy, Kerr Rachel, Saunders Mark P, Paul James, Harkin Andrea, McQueen John, Summers Matthew G, Johnstone Elaine, Wang Haitao, Gatcombe Laura, Maughan Timothy S, Kaplan Richard, Escott-Price Valentina, Al-Tassan Nada A, Meyer Brian F, Wakil Salma M, Houlston Richard S, Cheadle Jeremy P, Tomlinson Ian, Church David |
| The Role of Formyl Peptide Receptor 1 Gene Polymorphisms in Human Colorectal Cancer. Journal of Cancer 2020 11 (12): 3580-3587. Li Shu-Qin, Yu Yang, Zhang Yan, Sun Yan-Ping, Li Xin-Xing, Su Ni |
| No impact of cancer and plague-relevant FPR1 polymorphisms on COVID-19. Oncoimmunology 2020 12 9 (1): 1857112. Petrazzuolo Adriana, Le Naour Julie, Vacchelli Erika, Gaussem Pascale, Ellouze Syrine, Jourdi Georges, Solary Eric, Fontenay Michaela, Smadja David M, Kroemer Gui |
| A TLR3 Ligand Reestablishes Chemotherapeutic Responses in the Context of FPR1 Deficiency. Cancer discovery 2020 10 11 (2): 408-423. Le Naour Julie, Liu Peng, Zhao Liwei, Adjemian Sandy, Sztupinszki Zsofia, Taieb Julien, Mulot Claire, Silvin Aymeric, Dutertre Charles-Antoine, Ginhoux Florent, Sauvat Allan, Cerrato Giulia, Castoldi Francesca, Martins Isabelle, Stoll Gautier, Paillet Juliette, Mangane Khady, Richter Cornelia, Kepp Oliver, Maiuri Maria Chiara, Pietrocola Federico, Vandenabeele Peter, André Fabrice, Delaloge Suzette, Szallasi Zoltan, Laurent-Puig Pierre, Zucman-Rossi Jessica, Zitvogel Laurence, Pol Jonathan G, Vacchelli Erika, Kroemer Gui |
| Polymorphism of formyl peptide receptor 1 (FPR1) reduces the therapeutic efficiency and antitumor immunity after neoadjuvant chemoradiotherapy (CCRT) treatment in locally advanced rectal cancer. Cancer immunology, immunotherapy : CII 2021 3 70 (10): 2937-2950. Chiang Shu-Fen, Huang Kevin Chih-Yang, Chen William Tzu-Liang, Chen Tsung-Wei, Ke Tao-Wei, Chao K S Cliffo |
| Rs867228 in FPR1 accelerates the manifestation of luminal B breast cancer. Oncoimmunology 2023 3 12 (1): 2189823. Carbonnier Vincent, Le Naour Julie, Bachelot Thomas, Vacchelli Erika, André Fabrice, Delaloge Suzette, Kroemer Gui |
- Page last reviewed:Feb 1, 2024
- Content source: